Clinical Trial Update: Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating icotinib in combination with chemotherapy versus chemotherapy alone in patients with non-small cell lung cancer who progressed after ic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN